EU
GW Pharma’s cannabidiol gains EC approval
April 21, 2021Research and Development EC, EU, cannabis
GW Pharmaceuticals has received European Commission (EC) approval for the type II variation application for Epidyolex (cannabidiol), as an adjunctive …
BioVersys receives €20 Million EU Financing to develop new antibiotics
April 14, 2021Research and Development EU
The European Investment Bank (EIB) and BioVersys AG, a clinical-stage pharmaceutical company, have today announced the signing of a €20 …
Incyte receives EC approval for Pemazyre
March 30, 2021Manufacturing and Production EU
Incyte have received approval from the European Commission (EC) for Pemazyre (pemigatinib), the first new treatment for adults with locally …
Novavax delays 100 million vaccines to the EU
March 26, 2021Medical Communications COVID-19, EU, Vaccine
Novavax is delaying the signing of a contract to supply COVID-19 vaccines to the EU, as the company warned it …
eTheRNA awarded €6.9 million TIGER Grant by European Commission
March 22, 2021Sales and Marketing Cancer, EU
eTheRNA immunotherapies, a clinical-stage company, has been awarded a grant of €6.9 million by the European Commission to develop a …
Netherlands suspends AstraZeneca vaccine despite safety assurances
March 15, 2021Medical Communications, Sales and Marketing AstraZeneca, COVID-19, EMA, EU, WHO
The Netherlands has become the latest country to suspend the use of the Oxford-AstraZeneca vaccine amid concerns it may cause …
Dynavax’s hepatitis B vaccine gets EU approval
February 23, 2021Manufacturing and Production EU, Vaccine, hepatitis B
The European Commission (EC) has granted marketing authorisation Dynavax Technologies Corporation’s HEPLISAV B vaccine for the active immunisation against hepatitis …
ViiV gets EU approval for children’s HIV treatment
January 13, 2021Research and Development EU, HIV, ViiV
ViiV Healthcare, the global specialist HIV company, has received marketing authorisation from the European Commission for Tivicay (dolutegravir) 5mg dispersible …
EU states to receive 100m extra doses of Pfizer-BioNTech vaccine
January 4, 2021Sales and Marketing COVID-19, EU, Pfizer, Vaccine
Pfizer and BioNTech have announced they will supply an additional 100 million doses of their COVID-19 vaccine, COMIRNATY, to the …
Dupixent becomes first systemic medicine approved in Europe for children with severe atopic dermatitis
November 30, 2020Sales and Marketing Dupixent, EU, Europe, Sanofi
The European Commission has moved to expand the existing authorisation of Sanofi and Regeneron’s Dupixent (dupilumab) in the European Union …
Guido Rasi steps down as EMA’s Executive Director, Emer Cooke to become first female in the role
November 13, 2020Medical Communications, Research and Development, Sales and Marketing COVID-19, EMA, EU, pharma
Professor Guido Rasi, Executive Director at the European Medicines Agency (EMA), serves his final day at the European regulator today, …
European Commission greenlights Insmed’s Arikayce for nontuberculous mycobacterial lung infections
October 29, 2020Sales and Marketing Arikayce, EU, lungs, pharma
The European Commission (EC) has given approval to Insmed Incorporated’s Arikayce (liposomal 590mg nebuliser dispersion) for the treatment of nontuberculous …
UK life sciences industry does not want no-deal Brexit, says ABPI Chief
October 19, 2020Sales and Marketing ABPI, EU, UK, brexit, pharma
Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a no-deal scenario with the European …
GSK confirms deal to supply 300 million COVID-19 vaccine doses to the EU
September 25, 2020Manufacturing and Production, Medical Communications COVID-19, EU, GSK, Vaccine
GlaxoSmithKline has confirmed a new COVID-19 vaccine supply deal to deliver 300 million doses of its candidate to the European …
EU reportedly in talks with J&J to secure doses of its COVID-19 vaccine
June 19, 2020Medical Communications, Research and Development, Sales and Marketing COVID-19, EU, Europe, J&J, JJ, Vaccine
It has been reported that the European Union is currently negotiating a deal with pharma giant Johnson & Johnson to …
Latest content
